Provided by Tiger Trade Technology Pte. Ltd.

Sensei Biotherapeutics, Inc.

31.56
+1.013.31%
Post-market: 31.560.00000.00%19:53 EDT
Volume:108.19K
Turnover:3.44M
Market Cap:39.81M
PE:-1.65
High:33.62
Open:30.65
Low:30.12
Close:30.55
52wk High:36.76
52wk Low:5.00
Shares:1.26M
Float Shares:828.30K
Volume Ratio:0.97
T/O Rate:13.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-19.1560
EPS(LYR):-24.0130
ROE:-70.18%
ROA:-37.04%
PB:1.73
PE(LYR):-1.31

Loading ...

Jun 02, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 24, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 23, 2023

Major Issues Report

Form 8-K - Current report
May 09, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2023

Major Issues Report

8-K - Current report
May 01, 2023

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Apr 20, 2023

Major Issues Report

8-K - Current report
Mar 29, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 29, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 28, 2023

Major Issues Report

8-K - Current report
Mar 13, 2023

Major Issues Report

8-K - Current report
Mar 10, 2023

Major Issues Report

8-K - Current report
Mar 09, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Mar 07, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 06, 2023

Major Issues Report

8-K - Current report
Dec 09, 2022

Major Issues Report

8-K - Current report
Dec 08, 2022

Major Issues Report

8-K - Current report
Nov 21, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 10, 2022

Major Issues Report

8-K - Current report